✦ LIBER ✦

A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation

✍ Scribed by Pecora, A L; Stiff, P; LeMaistre, C F; Bayer, R; Bachier, C; Goldberg, S L; Parthasarathy, M; Jennis, A A; Smith, A K; Douville, J

Book ID: 110013151
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 129 KB
Volume: 28
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1703137

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II study on the safety and effic

A Phase II study on the safety and efficacy of a single dose of pegfilgrastim for mobilization and transplantation of autologous hematopoietic stem cells in pediatric oncohematology patients

✍ Simone Cesaro; Andrea Giulio Zanazzo; Stefano Frenos; Roberto Luksch; Anna Pegor 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 86 KB

A prospective, double-blind phase II stu

A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation

✍ Elad, S; Ackerstein, A; Bitan, M; Shapira, M Y; Resnick, I; Gesundheit, B; Cohen 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 137 KB

Phase I/II trial of cure-oriented high-d

Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies

✍ Michinori Ogura; Yoshitoyo Kagami; Ritsuro Suzuki; Kazuhisa Miura; Kazutaka Uehi 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 141 KB

A Phase I dose escalation trial of conti

A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma

✍ Todd M. Zimmerman; David L. Grinblatt; Rebecca Malloy; Stephanie F. Williams 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

## BACKGROUND. Paclitaxel, an effective chemotherapeutic agent in the management of breast carcinoma, may have activity in women whose disease has recurred after high dose chemotherapy. With this is mind the authors explored the addition of a 120-hour continuous infusion of paclitaxel to a previou

The feasibility of neoadjuvant high-dose

The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma : Results of a phase II study

✍ Fikret Arpaci; Selmin Ataergin; Ahmet Ozet; Kaan Erler; Mustafa Basbozkurt; Ayha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract ## BACKGROUND The primary and secondary objectives of the current study were to improve the ≥ 90% tumor necrosis rate and assess the toxicity profile of the neoadjuvant high‐dose chemotherapy (HDC) regimen, respectively. ## METHODS Twenty‐two patients with AJCC Stage IIB high‐grade o

Effect of dosing frequency on the safety

Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial

✍ K. Gebauer; S. Shumack; P.S.J. Cowen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB